All stock lists
Climb Bio, Inc. (NASDAQ:CLYM)
US · Delayed Price · Currency is USD
Also listed: ELYMHealthcare · Biotechnology
8.92-1.27 (-12.45%)
Insider Score
––Not scored
CLYM Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CLYM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 38.00 K | 30.00 K | 0.00 | 38.00 K | 0.00 |
| Gross Profit | 0.00 | -38.00 K | -30.00 K | 0.00 | -38.00 K | 0.00 |
| SG&A Expense | 5.64 M | 5.84 M | 5.53 M | 5.82 M | 4.10 M | 5.69 M |
| R&D Expense | 9.71 M | 9.34 M | 13.74 M | 9.07 M | 6.58 M | 17.33 M |
| Operating Expenses | 15.36 M | 15.17 M | 19.27 M | 14.89 M | 10.64 M | 23.02 M |
| Operating Income | -15.36 M | -15.21 M | -19.30 M | -14.89 M | -10.68 M | -23.02 M |
| Pretax Income | -13.50 M | -13.72 M | -17.52 M | -12.89 M | -8.67 M | -20.78 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -13.50 M | -13.72 M | -17.52 M | -12.89 M | -8.67 M | -20.78 M |
| EPS (Basic) | -0.18 | -0.20 | -0.26 | -0.19 | -0.13 | -0.31 |
| EPS (Diluted) | -0.18 | -0.20 | -0.26 | -0.19 | -0.13 | -0.31 |
| Shares Outstanding | 76.15 M | 68.21 M | 67.37 M | 67.83 M | 67.59 M | 67.46 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.